Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Scandinavian ChemoTech

2,11

 

SEK

 

+1,93 %

Mindre end 1K følgere

CMOTEC B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Sammenligne
+1,93%
+51,25%
+72,95%
+17,88%
+27,11%
-4,52%
-81,94%
-71,99%
-94,4%

Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.

Læs mere
Markedsværdi
49,26 mio. SEK
Aktieomsætning
17,85 t SEK
Omsætning
6,57 mio.
EBIT %
-194,82 %
P/E
-
Udbytteafkast, %
-
Finanskalender
12.8
2025

Delårsrapport Q2'25

4.11
2025

Delårsrapport Q3'25

3.3
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelse7.5.2025, 10.11

Redeye: Scandinavian ChemoTech - Momentum continues

Scandinavian ChemoTech
Selskabsmeddelelse6.5.2025, 06.30

Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025

Scandinavian ChemoTech
Pressemeddelelse2.5.2025, 06.30

(RETRANS) ChemoTech's Animal Care Celebrates Record-Breaking Month with Order Intake of 200,000 USD

Scandinavian ChemoTech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse1.5.2025, 04.15

ChemoTech's Animal Care Celebrates Record-Breaking Month with Order Intake of 200,000 USD in April

Scandinavian ChemoTech
Selskabsmeddelelse25.4.2025, 07.15

ChemoTech: Animal Care expands U.S. presence with new partnership, securing an order of appr. USD 66,000

Scandinavian ChemoTech
Selskabsmeddelelse1.4.2025, 07.15

Scandinavian ChemoTech Starts 2025 Strong with Q1 Order Intake Exceeding USD 230,000

Scandinavian ChemoTech
Selskabsmeddelelse21.3.2025, 11.53

Scandinavian ChemoTech Secures New Order and Expands Animal Care Operations Through Global Collaboration in Equine Oncology

Scandinavian ChemoTech
Pressemeddelelse4.3.2025, 17.45

Redeye: Scandinavian ChemoTech - Continued growth in recurring revenues

Scandinavian ChemoTech
Selskabsmeddelelse4.3.2025, 07.30

Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024

Scandinavian ChemoTech
Selskabsmeddelelse30.1.2025, 08.31

Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months

Scandinavian ChemoTech
Selskabsmeddelelse24.1.2025, 07.50

ChemoTech: Scandinavian ChemTech's Animal Care operations showed positive cashflow for 2024 in separate reporting

Scandinavian ChemoTech
Pressemeddelelse24.1.2025, 07.30

ChemoTech: Latest News: New Website for TSE - A Potential New Paradigm in Cancer Care

Scandinavian ChemoTech
Selskabsmeddelelse9.1.2025, 09.00

Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues

Scandinavian ChemoTech
Pressemeddelelse9.1.2025, 07.30

ChemoTech changes language for information disclosure

Scandinavian ChemoTech
Selskabsmeddelelse30.12.2024, 13.10

Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group

Scandinavian ChemoTech
Selskabsmeddelelse29.11.2024, 09.28

Scandinavian ChemoTech's Animal Care division is heading for a strong fourth quarter 2024 in terms of sales

Scandinavian ChemoTech
Selskabsmeddelelse5.11.2024, 08.20

ChemoTech's Animal Care Enters Strategic Collaboration with Norwegian Veterinary University's Hospital for Equine Medicine

Scandinavian ChemoTech
Pressemeddelelse1.11.2024, 09.30

ChemoTech: Animal Care Secures New Sale in Germany, Expanding Support for Veterinary Clinics Treating Domestic Animals

Scandinavian ChemoTech
Pressemeddelelse25.10.2024, 06.30

Scandinavian ChemoTech's Chief Medical Officer, Suhail Mufti, delivers clinical update

Scandinavian ChemoTech
Pressemeddelelse24.9.2024, 07.00

Scandinavian ChemoTech's Animal Care Announces New Partnership

Scandinavian ChemoTech
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.